Fireside Chat: Bridging the Gap Between Manufacturing & Regulatory Requirements for mRNA Platform Success
Time: 9:00 am
day: Day One
Details:
- How can mRNA platform capabilities be strategically mapped to streamline regulatory pathways and support the approval of subsequent products?
- How to leverage the learnings from approved mRNA technologies to facilitate a more straight-line development route with future pipelines?
- How to navigate new guidelines as a pre-approved mRNA drug developer to facilitate faster approvals while ensuring compliance with evolving standards?
- What are the regulatory guidelines and compliance challenges for traditional versus non-traditional mRNA therapeutics?
